Amantadine-Induced Corneal Edema in a Pediatric Neuro-Oncology Patient: A Case Report.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 29550414.
- Also identified by DOI 10.1016/j.pmrj.2018.03.007.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Amantadine is commonly prescribed as a neurostimulant in patients with brain injuries. This is a case of a 14-year-old male with a history of brain tumor that developed corneal edema after initiation of amantadine, a rare but documented side effect of this medication. After discontinuation of amantadine, the corneal edema resolved within two months, but endothelial cells density remained low. LEVEL OF EVIDENCE: V.
Medical subject headings
- Amantadine
- Brain Neoplasms
- Corneal Edema
- Neuroblastoma